Back to Index

MEDICAMEQ Daily Market Report

Date Range: 2021-10-27 to 2026-10-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Current Snapshot — MEDICAMEQ Report
Metric Value
Latest closed session 2026-10-26
Latest close 263.0000
20-session average turnover 6135633.20
Distance from 252-session high -36.59%

Trailing Price Returns

Trailing Price Returns — MEDICAMEQ Report
Sessions Return
1 3.81%
5 -7.54%
20 -14.19%
60 10.73%
120 2.19%
250 -16.94%

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Current Market Intelligence Candidates — MEDICAMEQ Report
Archetype Regime Primary horizon Strength First rejection risk
EVENT_GAP_REACTION BEAR_PERSISTENT 5 3.41 Gap fill and reversal below prior close
PRICE_DISLOCATION BEAR_PERSISTENT 120 0.24 Continued price deterioration or adverse fundamental evidence

Evidence Limits

Fundamental Research

Fundamental Research — MEDICAMEQ Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth 21.67%
Net margin 4.88%
Return on equity 3.50%
Debt/equity 0.17
Operating cash flow/net income -3.62
Free-cash-flow margin -20.08%
Trailing P/E N/A
Price/book N/A

Source: EODHD retrieved 2026-09-22T14:02:07.508772+00:00.

QA flags: weak_cash_conversion: operating cash flow/net income below 0.5

Missing statements mean data is unavailable. Balance-sheet equation flags require checking accounting definitions and units. Weak cash conversion and high leverage are financial risk observations, not necessarily data errors. A summary-only record cannot establish financial quality.

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.